Monday, March 5, 2012

Slow, costly process stymies generic biotech drugs (Reuters)

[unable to retrieve full-text content]Reuters - One of the pledges of the Obama administration's healthcare overhaul was to enable cheaper copies of expensive biotech drugs, but the savings may not be as deep or come as quickly as hoped.

Source: http://us.rd.yahoo.com/dailynews/rss/science/*http%3A//news.yahoo.com/s/nm/20120305/hl_nm/us_biosimilars

paranormal activity wvu football district 9 district 9 pandaria pandaria baby lisa irwin

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.